FDA approves J&J's prostate cancer drug Erleada in new use, ...

The FDA has approved Johnson & Johnson’s prostate cancer drug Erleada (apalutamide) for patients whose prostate cancer has spread.

Keytruda combo cleared as first-line kidney cancer treatment...

The top pharma companies by revenue 2018

Towards patient centricity: Pfizer

In a new series Amanda Barrell looks at how different companies are turning patient centricity into a reality.

2nd RNA Targeted Drug Discovery Summit

At a time when the previously untapped drug discovery opportunity promised within RNA opens up, the 

GlycoMimetics craters as Pfizer says rivipansel flunks trial